Related references
Note: Only part of the references are listed.Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications
Boris Gershman et al.
EUROPEAN UROLOGY (2017)
Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis
Sungmin Woo et al.
EUROPEAN UROLOGY (2017)
Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts
Rui Chen et al.
JOURNAL OF UROLOGY (2017)
ROLE OF MPMRI PSA DENSITY AND PIRADS SCORE IN PREDICTING UPSTAGING IN MEN ON ACTIVE SURVEILLANCE
Michelle Van Kuiken et al.
JOURNAL OF UROLOGY (2017)
DEVELOPMENT AND VALIDATION OF A NOMOGRAM FOR PREDICTING PIRADS 4-5 LESIONS ON MULTIPARAMETRIC PROSTATE MRI
Matthew Truong et al.
JOURNAL OF UROLOGY (2017)
The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction
Florian A. Distler et al.
JOURNAL OF UROLOGY (2017)
Developing a new PI-RADS v2-based nomogram for forecasting high-grade prostate cancer
X. -k. Niu et al.
CLINICAL RADIOLOGY (2017)
The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer
Chenglin Zhao et al.
CLINICAL IMAGING (2016)
Assessment of PI-RADS v2 for the Detection of Prostate Cancer
Moritz Kasel-Seibert et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
Eduard Baco et al.
EUROPEAN UROLOGY (2016)
A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort
Katharina Braun et al.
EUROPEAN UROLOGY (2016)
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries
Martin C. S. Wong et al.
EUROPEAN UROLOGY (2016)
Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use
Jelle O. Barentsz et al.
EUROPEAN UROLOGY (2016)
Clinical predictors of PIRADS≥3 lesions on MP-MRI in patients with negative prior prostate biopsies and a persisting clinical suspicion on prostate cancer
O. Wegelin et al.
EUROPEAN UROLOGY SUPPLEMENTS (2016)
Validation of PI-RADS v.2 for prostate cancer diagnosis with MRI at 3T using an external phased-array coil
Matteo Baldisserotto et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy
Rui Chen et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Futterer et al.
EUROPEAN UROLOGY (2015)
Magnetic Resonance Imaging-targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis
Ivo G. Schoots et al.
EUROPEAN UROLOGY (2015)
Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer
Donna P. Ankerst et al.
UROLOGY (2014)
The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
Guillaume Ploussard et al.
EUROPEAN UROLOGY (2011)
Number of prostate cancer risk alleles may identify possibly 'insignificant' disease
Brian T. Helfand et al.
BJU INTERNATIONAL (2010)
Preoperative Prediction of Pathologically Insignificant Prostate Cancer in Radical Prostatectomy Specimens: The Role of Prostate Volume and the Number of Positive Cores
Carles X. Raventos et al.
UROLOGIA INTERNATIONALIS (2010)
Share Paper
